A wearable pain-relief device will be unveiled at the International CES in Las Vegas this week as part of its digital health exhibit.
Quell, a novel wearable pain relief device, will be unveiled at the 2015 International Consumer Electronics show (CES) running from January 6 to 9 in Las Vegas.
Attendees will get their first glimpse of Quell at the NeuroMetrix booth in the Digital Health section of CES. NeuroMetrix, a health-care company that develops wearable medical technology and point-of-care tests, will also be one of an exclusive group that will participate in CES Unveiled, the official press event of CES.
Quell utilizes NeuroMetrix’s proprietary non-invasive neurostimulation technology to provide relief from chronic pain, such as due to diabetes, sciatica, fibromyalgia, and degenerative knee conditions. The advanced wearable device is lightweight and can be worn during the day while active, and at night while sleeping.
It has been cleared by the FDA for treatment of chronic pain without a prescription. Users of the device will also have the option of using their smartphone to automatically track and personalise their pain therapy. The Company expects Quell to be available for purchase by consumers in the second quarter of 2015.
The company’s President and Chief Executive Officer, Dr Shai N. Gozani, will participate in a CES Digital Health Summit panel entitled “Winning the War on Diabetes.” Dr. Gozani commented
Recent studies have shown that chronic nerve pain dramatically reduces the quality of life of people with diabetes,” he said. “We believe that Quell may help many of these people reclaim their life from chronic pain.
* Follow Gadget on Twitter on @GadgetZA